Nordicnanovector Revenue and Competitors
Estimated Revenue & Valuation
- Nordicnanovector's estimated annual revenue is currently $3.1M per year.
- Nordicnanovector's estimated revenue per employee is $155,000
Employee Data
- Nordicnanovector has 20 Employees.
- Nordicnanovector grew their employee count by -66% last year.
Nordicnanovector Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $16.4M | 106 | 29% | N/A | N/A |
#2 | $2M | 13 | -24% | N/A | N/A |
#3 | $3.4M | 22 | 29% | N/A | N/A |
#4 | $3.1M | 20 | -66% | N/A | N/A |
#5 | $4.3M | 28 | 17% | N/A | N/A |
#6 | $7M | 45 | 2% | N/A | N/A |
#7 | $11.3M | 73 | -4% | N/A | N/A |
#8 | N/A | 45 | 29% | N/A | N/A |
What Is Nordicnanovector?
Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting Antibody-Radionuclide-Conjugates (ARC) designed to advance the treatment of non-Hodgkin's Lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 20 billion by 2024. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets.
keywords:N/AN/A
Total Funding
20
Number of Employees
$3.1M
Revenue (est)
-66%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nordicnanovector's People
Name | Title | Email/Phone |
---|---|---|
1 | CSO | Reveal Email/Phone |
Nordicnanovector News
Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer...
Nordic Nanovector ASA Announces Proposed Board Changes - Former Algeta CEO Thomas Ramdahl nominated to Join Board of Directors.
Nordic Nanovector ASA - Notice of Annual General Meeting on 28 April 2022. Published: Apr 06, 2022. OSLO, Norway, April 6, 2022 /PRNewswire/ -- Notice is...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.9M | 20 | 0% | N/A |
#2 | $3.4M | 20 | 0% | N/A |
#3 | $4.1M | 20 | 67% | N/A |
#4 | $2M | 20 | 33% | N/A |
#5 | $1.8M | 20 | -13% | N/A |